That is a very good question and one that I would have expected the ompany to have expanded on.
The trials are complete so unlike the product is headed to those who need it!
Since I believe the product used for the recent tial was required to made to comply to commercial batch standards..as the literature on the web suggests...does this mean it came from PP and out of the UK?
So I am guessing that the 20,000 which in commercial terms is very small is to valid that Therapex can make the product to the required medical and commercial standards.
The question is now..is EMS planning to go it alone to have the product registered in an Africa country, may be one where the trials were held...if yes...it would mean that a trade sale is further way than we think!
Anyone else have a view?
manufacturing update, page-29
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
